William R. Boudreaux

Clients benefit from Bill's rare combination of legal acumen and insider knowledge of the pharmaceutical industry. His experience as primary patent counsel for several blockbuster drugs at major companies like Eli Lilly and Pfizer gives him invaluable insight into the pressures and dynamics faced by in-house teams. This enables Bill to provide distilled, actionable advice that resonates with both legal and business professionals alike.

Bill excels in advising on global patent portfolio management and pharmaceutical patent life-cycle planning. He guides clients through complex IP due diligence processes with the goal of ensuring their innovations are protected and leveraged effectively. His skills extend to freedom-to-operate and infringement and validity analyses, as well as strategic support for Hatch-Waxman litigation.

Over the course of his career, Bill has held leadership positions in patent prosecution and biotechnology practice groups. His comprehensive understanding of the pharmaceutical landscape, from the lab bench to the boardroom, makes him a trusted adviser for companies navigating the intricate world of life sciences patents and intellectual property.